WASHINGTON — Canada’s federal police refused to investigate or cooperate with the United States Drug Enforcement Administration on a British Columbia fentanyl superlab probe tied to chemical-precursor shipments from China into Vancouver in late 2022, according to senior U.S. officials. More than a year later — only after the U.S. Treasury sanctioned Iranian-Canadian businessman Bahman Djebelibak and his Health Canada–licensed company Valerian Labs, naming them as part of a Chinese fentanyl trafficking syndicate that Washington sought to disrupt — did the RCMP finally open a siloed investigation. The force continued to refuse coordination or information sharing with the American agents who had initiated the case. In an exclusive interview, Derek Maltz, DEA Acting Administrator in 2025 with oversight of the matter, called the B.C. superlab case a “major disaster.”
